INVO Fertility (IVF) Preferred Stock Liabilities (2024 - 2025)
INVO Fertility (IVF) reported Preferred Stock Liabilities of $4.0 million for Q1 2025, down 46.64% on a QoQ basis from $7.5 million in Q4 2024.
INVO Fertility (IVF) has 2 years of Preferred Stock Liabilities data on file, last reported at $4.0 million in Q1 2025.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $4.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $4.0 million (changed N/A YoY) and the FY2024 annual result came in at $7.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities eased to $4.0 million in Q1 2025 per IVF's latest filing, from $7.5 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $7.5 million in Q4 2024 and bottomed at $4.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 7.46 Mn |